$KBH
KB HOME Stock $kbh

$kbh Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000079526615000056 Filed on October 09, 2015

Income Statement

Concept	2015 Q3	2014 Q3
Revenue	$843.2M	$589.2M
YoY Change	43.1%	7.33%
Cost Of Revenue	$709.1M	$479.4M
YoY Change	47.91%	7.39%
Gross Profit	$133.1M	$108.9M
YoY Change	22.19%	6.97%
Gross Profit Margin	15.79%	18.49%
Selling, General & Admin	$95.07M	$72.90M
YoY Change	30.42%	14.88%
% of Gross Profit	71.43%	66.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$900.0K	$700.0K
YoY Change	28.57%	40.0%
% of Gross Profit	0.68%	0.64%
Operating Expenses	$95.07M	$72.90M
YoY Change	30.42%	14.88%
Operating Profit	$35.98M	$33.91M
YoY Change	6.11%	-5.71%
Interest Expense	$4.394M	$6.455M
YoY Change	-31.93%	-43.01%
% of Operating Profit	12.21%	19.04%
Other Income/Expense, Net
YoY Change
Pretax Income	$33.95M	$28.66M
YoY Change	18.47%	7.84%
Income Tax	$10.70M	$300.0K
% Of Pretax Income	31.51%	1.05%
Net Earnings	$23.25M	$28.36M
YoY Change	-18.01%	3.97%
Net Earnings / Revenue	2.76%	4.81%
Basic Earnings Per Share	$0.25	$0.31
Diluted Earnings Per Share	$0.23	$0.28
COMMON SHARES
Basic Shares Outstanding	92.07M shares	91.79M shares
Diluted Shares Outstanding	101.9M shares	102.1M shares

Balance Sheet

Concept	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$353.0M	$297.1M
YoY Change	18.82%	-22.49%
Cash & Equivalents	$354.9M	$299.0M
Short-Term Investments
Other Short-Term Assets	$34.60M	$36.50M
YoY Change	-5.21%	33.21%
Inventory	$3.402B	$3.240B
Prepaid Expenses
Receivables	$159.6M	$117.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.949B	$3.691B
YoY Change	6.98%	36.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.43M	$10.94M
YoY Change	13.62%	38.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$84.80M	$82.00M
YoY Change	3.41%	-39.97%
Other Assets	$835.0M	$32.50M
YoY Change	2469.23%	-21.88%
Total Long-Term Assets	$999.6M	$196.1M
YoY Change	409.76%	-22.23%
TOTAL ASSETS
Total Short-Term Assets	$3.949B	$3.691B
Total Long-Term Assets	$999.6M	$196.1M
Total Assets	$4.948B	$3.887B
YoY Change	27.3%	31.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$178.6M	$168.0M
YoY Change	6.31%	14.99%
Accrued Expenses	$470.9M	$369.6M
YoY Change	27.41%	12.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$491.1M	$537.6M
YoY Change	-8.65%	13.13%
LONG-TERM LIABILITIES
Long-Term Debt	$2.631B	$2.581B
YoY Change	1.93%	33.23%
Other Long-Term Liabilities	$7.800M	$22.60M
YoY Change	-65.49%	-56.2%
Total Long-Term Liabilities	$2.639B	$2.603B
YoY Change	1.35%	30.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$491.1M	$537.6M
Total Long-Term Liabilities	$2.639B	$2.603B
Total Liabilities	$3.308B	$3.143B
YoY Change	5.27%	27.4%
SHAREHOLDERS EQUITY
Retained Earnings	$1.425B	$540.8M
YoY Change	163.52%	18.62%
Common Stock	$795.1M	$781.2M
YoY Change	1.78%	-13.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$446.8M	$446.0M
YoY Change	0.18%	-37.89%
Treasury Stock Shares
Shareholders Equity	$1.640B	$744.6M
YoY Change
Total Liabilities & Shareholders Equity	$4.948B	$3.887B
YoY Change	27.3%	31.12%

Cashflow Statement

Concept	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$23.25M	$28.36M
YoY Change	-18.01%	3.97%
Depreciation, Depletion And Amortization	$900.0K	$700.0K
YoY Change	28.57%	40.0%
Cash From Operating Activities	$113.8M	-$162.2M
YoY Change	-170.16%	21.14%
INVESTING ACTIVITIES
Capital Expenditures	-$500.0K	-$1.200M
YoY Change	-58.33%	100.0%
Acquisitions
YoY Change
Other Investing Activities	$6.200M	-$17.80M
YoY Change	-134.83%	304.55%
Cash From Investing Activities	$5.700M	-$19.00M
YoY Change	-130.0%	280.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-206.8M	-7.200M
YoY Change	2772.22%	-54.43%
NET CHANGE
Cash From Operating Activities	113.8M	-162.2M
Cash From Investing Activities	5.700M	-19.00M
Cash From Financing Activities	-206.8M	-7.200M
Net Change In Cash	-87.30M	-188.4M
YoY Change	-53.66%	21.78%
FREE CASH FLOW
Cash From Operating Activities	$113.8M	-$162.2M
Capital Expenditures	-$500.0K	-$1.200M
Free Cash Flow	$114.3M	-$161.0M
YoY Change	-170.99%	20.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	6890000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-08-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000795266
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	92071598	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	KB Home
	dei	Trading Symbol TradingSymbol	KBH
CY2014Q4	kbh	Acquisition Costs Related To Land Option Contracts And Other Similar Contracts AcquisitionCostsRelatedToLandOptionContractsAndOtherSimilarContracts	48000000	USD
CY2015Q3	kbh	Acquisition Costs Related To Land Option Contracts And Other Similar Contracts AcquisitionCostsRelatedToLandOptionContractsAndOtherSimilarContracts	60000000	USD
CY2014Q4	kbh	Aggregate Carrying Value Of Inventory Impacted By Pretax Noncash Inventory Impairment Charges AggregateCarryingValueOfInventoryImpactedByPretaxNoncashInventoryImpairmentCharges	266600000	USD
CY2015Q3	kbh	Aggregate Carrying Value Of Inventory Impacted By Pretax Noncash Inventory Impairment Charges AggregateCarryingValueOfInventoryImpactedByPretaxNoncashInventoryImpairmentCharges	248300000	USD
CY2014Q4	kbh	Aggregate Purchase Price Associated With Land Option And Other Similar Contracts AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts	958470000	USD
CY2015Q3	kbh	Aggregate Purchase Price Associated With Land Option And Other Similar Contracts AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts	941596000	USD
CY2014Q3	kbh	Carrying Valueof Communitiesor Land Parcels Evaluatedfor Impairment CarryingValueofCommunitiesorLandParcelsEvaluatedforImpairment	207400000	USD
CY2015Q3	kbh	Carrying Valueof Communitiesor Land Parcels Evaluatedfor Impairment CarryingValueofCommunitiesorLandParcelsEvaluatedforImpairment	232800000	USD
CY2014Q4	kbh	Cash Deposits On Land Option And Other Similar Contracts CashDepositsOnLandOptionAndOtherSimilarContracts	33059000	USD
CY2015Q3	kbh	Cash Deposits On Land Option And Other Similar Contracts CashDepositsOnLandOptionAndOtherSimilarContracts	42771000	USD
CY2014Q4	kbh	Equity Method Investment Summarized Financial Information Accounts Payable And Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccountsPayableAndOtherLiabilities	10824000	USD
CY2015Q3	kbh	Equity Method Investment Summarized Financial Information Accounts Payable And Other Liabilities EquityMethodInvestmentSummarizedFinancialInformationAccountsPayableAndOtherLiabilities	16832000	USD
CY2014Q4	kbh	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	23699000	USD
CY2015Q3	kbh	Equity Method Investment Summarized Financial Information Cash EquityMethodInvestmentSummarizedFinancialInformationCash	23454000	USD
CY2014Q4	kbh	Equity Method Investment Summarized Financial Information Inventories EquityMethodInvestmentSummarizedFinancialInformationInventories	153427000	USD
CY2015Q3	kbh	Equity Method Investment Summarized Financial Information Inventories EquityMethodInvestmentSummarizedFinancialInformationInventories	169471000	USD
CY2014Q4	kbh	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	0	USD
CY2014Q4	kbh	Equity Method Investment Summarized Financial Information Receivable EquityMethodInvestmentSummarizedFinancialInformationReceivable	5106000	USD
CY2015Q3	kbh	Equity Method Investment Summarized Financial Information Receivable EquityMethodInvestmentSummarizedFinancialInformationReceivable	7631000	USD
CY2015Q3	kbh	Equity Method Investment Summarized Financial Information Other Assets EquityMethodInvestmentSummarizedFinancialInformationOtherAssets	658000	USD
CY2014Q3	kbh	Equity Method Investment Summarized Financial Information Other Income Expenses Net EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpensesNet	-1050000	USD
	kbh	Equity Method Investment Summarized Financial Information Other Income Expenses Net EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpensesNet	-3088000	USD
CY2015Q3	kbh	Equity Method Investment Summarized Financial Information Other Income Expenses Net EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpensesNet	-753000	USD
	kbh	Equity Method Investment Summarized Financial Information Other Income Expenses Net EquityMethodInvestmentSummarizedFinancialInformationOtherIncomeExpensesNet	-2164000	USD
CY2014Q4	kbh	Equity Method Investments Summarized Financial Information Debt EquityMethodInvestmentsSummarizedFinancialInformationDebt	0	USD
CY2015Q3	kbh	Equity Method Investments Summarized Financial Information Debt EquityMethodInvestmentsSummarizedFinancialInformationDebt	31963000	USD
CY2014Q3	kbh	Expenses Associated With Self Insurance ExpensesAssociatedWithSelfInsurance	3108000	USD
	kbh	Expenses Associated With Self Insurance ExpensesAssociatedWithSelfInsurance	8761000	USD
CY2015Q3	kbh	Expenses Associated With Self Insurance ExpensesAssociatedWithSelfInsurance	4694000	USD
	kbh	Expenses Associated With Self Insurance ExpensesAssociatedWithSelfInsurance	11919000	USD
CY2015Q3	kbh	Fair Value Estimate Input Average Selling Price FairValueEstimateInputAverageSellingPrice	178100	USD
	kbh	Fair Value Estimate Input Average Selling Price FairValueEstimateInputAverageSellingPrice	178100	USD
CY2015Q3	kbh	Fair Value Estimate Input Delivery For Period FairValueEstimateInputDeliveryForPeriod	4	delivery
	kbh	Fair Value Estimate Input Delivery For Period FairValueEstimateInputDeliveryForPeriod	4	delivery
CY2014Q4	kbh	Gross Unrecognized Tax Benefits Including Interest And Penalties GrossUnrecognizedTaxBenefitsIncludingInterestAndPenalties	300000	USD
CY2015Q3	kbh	Gross Unrecognized Tax Benefits Including Interest And Penalties GrossUnrecognizedTaxBenefitsIncludingInterestAndPenalties	100000	USD
	kbh	Increase Decrease In Consolidated Inventories Not Owned IncreaseDecreaseInConsolidatedInventoriesNotOwned	-4931000	USD
	kbh	Increase Decrease In Consolidated Inventories Not Owned IncreaseDecreaseInConsolidatedInventoriesNotOwned	86211000	USD
CY2014Q4	kbh	Increase In Inventories And Accrued Expenses And Other Liabilities Due To Land Option And Other Similar Contracts IncreaseInInventoriesAndAccruedExpensesAndOtherLiabilitiesDueToLandOptionAndOtherSimilarContracts	3100000	USD
CY2015Q3	kbh	Increase In Inventories And Accrued Expenses And Other Liabilities Due To Land Option And Other Similar Contracts IncreaseInInventoriesAndAccruedExpensesAndOtherLiabilitiesDueToLandOptionAndOtherSimilarContracts	89400000	USD
CY2014Q3	kbh	Intercompany Interest Income Expense IntercompanyInterestIncomeExpense	0	USD
	kbh	Intercompany Interest Income Expense IntercompanyInterestIncomeExpense	0	USD
CY2015Q3	kbh	Intercompany Interest Income Expense IntercompanyInterestIncomeExpense	0	USD
	kbh	Intercompany Interest Income Expense IntercompanyInterestIncomeExpense	0	USD
CY2014Q4	kbh	Inventory Impactedby Pretax Noncash Inventory Impairment Charges Carrying Value InventoryImpactedbyPretaxNoncashInventoryImpairmentChargesCarryingValue	68200000	USD
CY2015Q3	kbh	Inventory Impactedby Pretax Noncash Inventory Impairment Charges Carrying Value InventoryImpactedbyPretaxNoncashInventoryImpairmentChargesCarryingValue	6600000	USD
	kbh	Inventory Impairments And Land Option Contract Abandonments InventoryImpairmentsAndLandOptionContractAbandonments	5211000	USD
	kbh	Inventory Impairments And Land Option Contract Abandonments InventoryImpairmentsAndLandOptionContractAbandonments	4516000	USD
CY2014Q4	kbh	Inventoryrelatedliabilities Inventoryrelatedliabilities	52009000	USD
CY2015Q3	kbh	Inventoryrelatedliabilities Inventoryrelatedliabilities	129874000	USD
CY2014Q3	kbh	Land Option Contract Abandonment Lots LandOptionContractAbandonmentLots	624	lot
	kbh	Land Option Contract Abandonment Lots LandOptionContractAbandonmentLots	1306	lot
CY2015Q3	kbh	Land Option Contract Abandonment Lots LandOptionContractAbandonmentLots	740	lot
	kbh	Land Option Contract Abandonment Lots LandOptionContractAbandonmentLots	1166	lot
CY2014Q3	kbh	Land Option Contract Abandonment Lots Associatedwith Projects Less Than100000 LandOptionContractAbandonmentLotsAssociatedwithProjectsLessThan100000	1651	lot
	kbh	Land Option Contract Abandonment Lots Associatedwith Projects Less Than100000 LandOptionContractAbandonmentLotsAssociatedwithProjectsLessThan100000	7018	lot
CY2015Q3	kbh	Land Option Contract Abandonment Lots Associatedwith Projects Less Than100000 LandOptionContractAbandonmentLotsAssociatedwithProjectsLessThan100000	0	lot
	kbh	Land Option Contract Abandonment Lots Associatedwith Projects Less Than100000 LandOptionContractAbandonmentLotsAssociatedwithProjectsLessThan100000	0	lot
	kbh	Lettersof Credit Outstanding Term LettersofCreditOutstandingTerm	P1Y
	kbh	Lineof Credit Facility Non Guarantor Subsidiary Threshold Percent LineofCreditFacilityNonGuarantorSubsidiaryThresholdPercent	0.10
	kbh	Lineof Credit Facility Significant Subsidiary Threshold Percent LineofCreditFacilitySignificantSubsidiaryThresholdPercent	0.05
	kbh	Maximum Warranty On Electrical Heating Cooling Plumbing And Other Building Systems MaximumWarrantyOnElectricalHeatingCoolingPlumbingAndOtherBuildingSystems	P5Y
	kbh	Minimum Warranty On Electrical Heating Cooling Plumbing And Other Building Systems MinimumWarrantyOnElectricalHeatingCoolingPlumbingAndOtherBuildingSystems	P2Y
CY2014Q4	kbh	Number Of Communities And Various Other Land Parcels Impacted By Pretax Noncash Inventory Impairment Charges NumberOfCommunitiesAndVariousOtherLandParcelsImpactedByPretaxNoncashInventoryImpairmentCharges	33	property
CY2015Q3	kbh	Number Of Communities And Various Other Land Parcels Impacted By Pretax Noncash Inventory Impairment Charges NumberOfCommunitiesAndVariousOtherLandParcelsImpactedByPretaxNoncashInventoryImpairmentCharges	25	lot
CY2014Q4	kbh	Number Of Investments In Unconsolidated Joint Ventures NumberOfInvestmentsInUnconsolidatedJointVentures	6	joint_venture
CY2015Q3	kbh	Number Of Investments In Unconsolidated Joint Ventures NumberOfInvestmentsInUnconsolidatedJointVentures	7	joint_venture
	kbh	Number Of Land Parcels Or Communities Evaluated For Recoverability NumberOfLandParcelsOrCommunitiesEvaluatedForRecoverability	25	property
	kbh	Number Of Land Parcels Or Communities Evaluated For Recoverability NumberOfLandParcelsOrCommunitiesEvaluatedForRecoverability	29	property
CY2014Q4	kbh	Numberof Unconsolidated Joint Venture Lots Controlled Under Land Option Contracts NumberofUnconsolidatedJointVentureLotsControlledUnderLandOptionContracts	618	lot
CY2015Q3	kbh	Numberof Unconsolidated Joint Venture Lots Controlled Under Land Option Contracts NumberofUnconsolidatedJointVentureLotsControlledUnderLandOptionContracts	538	lot
CY2014Q4	kbh	Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Or Other Similar Contracts OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionOrOtherSimilarContracts	100000	USD
CY2015Q3	kbh	Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Or Other Similar Contracts OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionOrOtherSimilarContracts	0	USD
	kbh	Ownership Share In Guarantor Subsidiaries OwnershipShareInGuarantorSubsidiaries	1
CY2014Q3	kbh	Payments Netof Recoveriesfor Self Insurance PaymentsNetofRecoveriesforSelfInsurance	-5257000	USD
	kbh	Payments Netof Recoveriesfor Self Insurance PaymentsNetofRecoveriesforSelfInsurance	-12666000	USD
CY2015Q3	kbh	Payments Netof Recoveriesfor Self Insurance PaymentsNetofRecoveriesforSelfInsurance	-4229000	USD
	kbh	Payments Netof Recoveriesfor Self Insurance PaymentsNetofRecoveriesforSelfInsurance	-17892000	USD
CY2014Q4	kbh	Performance Bonds PerformanceBonds	541600000	USD
CY2015Q3	kbh	Performance Bonds PerformanceBonds	542900000	USD
CY2014Q4	kbh	Self Insuranceand Other Litigation Liabilities SelfInsuranceandOtherLitigationLiabilities	89606000	USD
CY2015Q3	kbh	Self Insuranceand Other Litigation Liabilities SelfInsuranceandOtherLitigationLiabilities	94303000	USD
CY2014Q3	kbh	Title Services TitleServices	904000	USD
	kbh	Title Services TitleServices	2503000	USD
CY2015Q3	kbh	Title Services TitleServices	1096000	USD
	kbh	Title Services TitleServices	2769000	USD
CY2014Q3	kbh	Undistributed Earnings Reallocatedto Participating Securities UndistributedEarningsReallocatedtoParticipatingSecurities	66000	USD
	kbh	Undistributed Earnings Reallocatedto Participating Securities UndistributedEarningsReallocatedtoParticipatingSecurities	142000	USD
CY2015Q3	kbh	Undistributed Earnings Reallocatedto Participating Securities UndistributedEarningsReallocatedtoParticipatingSecurities	57000	USD
	kbh	Undistributed Earnings Reallocatedto Participating Securities UndistributedEarningsReallocatedtoParticipatingSecurities	104000	USD
	kbh	Warranty For Other Components Of Home WarrantyForOtherComponentsOfHome	P1Y
CY2014Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	125488000	USD
CY2015Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	159576000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	582598000	USD
CY2015Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	675762000	USD
CY2014Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	172716000	USD
CY2015Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	178604000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	113875000	USD
CY2015Q3	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	110061000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	409882000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	497158000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21008000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21008000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	668857000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	679600000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10444000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5246000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5866000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5200000	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5700000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5700000	shares
CY2014Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3408000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3408000	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	37600000	USD
CY2015Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3173000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3173000	USD
CY2014Q4	us-gaap	Assets Assets	4757550000	USD
CY2015Q3	us-gaap	Assets Assets	4948496000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	532523000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	299008000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	358768000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	354879000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-233515000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3889000	USD
CY2014Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	197700000	USD
CY2015Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	231000000	USD
CY2014Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	70571000	USD
CY2015Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	67357000	USD
CY2015Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12602735	shares
CY2014Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.0250
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.075
CY2015Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.0250
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.075
CY2014Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0250
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.075
CY2015Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0250
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.075
CY2014Q4	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	112106000	USD
CY2015Q3	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	112106000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	115387000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	115524000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28400000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	65500000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23300000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40600000	USD
CY2014Q3	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	479424000	USD
	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	1305258000	USD
CY2015Q3	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	709148000	USD
	us-gaap	Construction And Development Costs ConstructionAndDevelopmentCosts	1725976000	USD
CY2014Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	15197000	USD
CY2015Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	18436000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	27082000	USD
CY2015Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	26896000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	866400000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	851200000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	825232000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	810016000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41200000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41200000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1677000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2547000	USD
CY2014Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2015Q3	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2014Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2015Q3	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.74
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.315
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.289
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	182232000	USD
CY2015Q3	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	201214000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	0	USD
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	3523000	USD
CY2015Q3	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	3381000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	17373000	USD
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	171408000	USD
CY2015Q3	us-gaap	Equity Method Investment Summarized Financial Information Equity Or Capital EquityMethodInvestmentSummarizedFinancialInformationEquityOrCapital	152419000	USD
CY2014Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	182232000	USD
CY2015Q3	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	201214000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-1050000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-493000	USD
CY2015Q3	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-796000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-9779000	USD
CY2014Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	0	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	6118000	USD
CY2015Q3	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	3338000	USD
	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	9758000	USD
CY2015Q3	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.2	Rate
	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.2	Rate
CY2014Q3	us-gaap	Financial Services Costs FinancialServicesCosts	859000	USD
	us-gaap	Financial Services Costs FinancialServicesCosts	2563000	USD
CY2015Q3	us-gaap	Financial Services Costs FinancialServicesCosts	910000	USD
	us-gaap	Financial Services Costs FinancialServicesCosts	2802000	USD
CY2014Q4	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	2517000	USD
CY2015Q3	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	1776000	USD
CY2014Q3	us-gaap	Financial Services Revenue FinancialServicesRevenue	2983000	USD
	us-gaap	Financial Services Revenue FinancialServicesRevenue	8014000	USD
CY2015Q3	us-gaap	Financial Services Revenue FinancialServicesRevenue	2953000	USD
	us-gaap	Financial Services Revenue FinancialServicesRevenue	7351000	USD
CY2014Q3	us-gaap	Home Building Revenue HomeBuildingRevenue	586231000	USD
	us-gaap	Home Building Revenue HomeBuildingRevenue	1596894000	USD
CY2015Q3	us-gaap	Home Building Revenue HomeBuildingRevenue	840204000	USD
	us-gaap	Home Building Revenue HomeBuildingRevenue	2038896000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	28661000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	66348000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	33954000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	57126000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	872000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1843000	USD
CY2014Q3	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2015Q3	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2015Q3	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	-2500000	USD
	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	-5600000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16500000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1537000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2915000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	27754000	USD
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	25032000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20388000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1952000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-15216000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	784457000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	72509000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	7608000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-37000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8402000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8402000	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8402000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	8402000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1875000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1823000	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1407000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1198000	shares
CY2014Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	1832000	USD
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	4364000	USD
CY2015Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	1857000	USD
	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	4581000	USD
CY2014Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
CY2015Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	1000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	6455000	USD
	us-gaap	Interest Expense InterestExpense	26289000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	110000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	393000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	87000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	342000	USD
CY2014Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	79441000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	4394000	USD
	us-gaap	Interest Expense InterestExpense	17850000	USD
CY2014Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	667000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2000000	USD
CY2015Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	667000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	2000000	USD
	us-gaap	Interest Paid Net InterestPaidNet	312000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5017000	USD
CY2014Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	63275000	USD
CY2015Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	76108000	USD
CY2014Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	928272000	USD
CY2015Q3	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	1187576000	USD
CY2014Q4	us-gaap	Inventory Land Held For Development And Sale InventoryLandHeldForDevelopmentAndSale	579966000	USD
CY2015Q3	us-gaap	Inventory Land Held For Development And Sale InventoryLandHeldForDevelopmentAndSale	527487000	USD
CY2014Q4	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	3218387000	USD
CY2015Q3	us-gaap	Inventory Operative Builders InventoryOperativeBuilders	3401737000	USD
CY2014Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1710149000	USD
CY2015Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1686674000	USD
CY2015Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	72800000	USD
CY2014Q4	us-gaap	Investments In And Advances To Affiliates Amount Of Equity InvestmentsInAndAdvancesToAffiliatesAmountOfEquity	0	USD
CY2015Q3	us-gaap	Investments In And Advances To Affiliates Amount Of Equity InvestmentsInAndAdvancesToAffiliatesAmountOfEquity	0	USD
CY2014Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	26700000	USD
CY2015Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	26400000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4757550000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4948496000	USD
CY2015Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	200000000	USD
CY2015Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	275000000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1400000000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	15800000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	630000000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	300000000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	265000000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	25400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	511229000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27250000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28082000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9055000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-716662000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22084000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	28361000	USD
	us-gaap	Net Income Loss NetIncomeLoss	65548000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	23254000	USD
	us-gaap	Net Income Loss NetIncomeLoss	40626000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28282000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	65371000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	23184000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	40487000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28956000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	67388000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	4158000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	2100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	46000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	300000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	23857000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	42498000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	52561000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	16730000	USD
CY2014Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2576525000	USD
CY2015Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	2630732000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5	segment
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	33910000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	85921000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	35982000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	68242000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	17040000	USD
CY2015Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	7799000	USD
CY2014Q4	us-gaap	Other Assets OtherAssets	114915000	USD
CY2015Q3	us-gaap	Other Assets OtherAssets	114352000	USD
CY2014Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	6000	USD
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	18000	USD
CY2015Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	7000	USD
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	24000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5448000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4561000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6682000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6890000	USD
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	34034000	USD
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	20955000	USD
CY2015Q3	us-gaap	Pledged Assets Not Separately Reported Real Estate PledgedAssetsNotSeparatelyReportedRealEstate	145000000	USD
CY2014Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	5431000	USD
CY2015Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	7674000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	14000000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	400000000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	250000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	202000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	436000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	137045000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	9450000	USD
	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	2207000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-23292000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-13736000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	10110000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2014Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	7546000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	12155000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	1130000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	8164000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11831000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12425000	USD
CY2013Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	216681000	USD
CY2014Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	241583000	USD
CY2014Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	257962000	USD
CY2015Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	46587000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	140789000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	199906000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27235000	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	25028000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1391256000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1424992000	USD
CY2014Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	266668000	USD
CY2015Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	299678000	USD
CY2015Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	290119000	USD
CY2014Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	21769000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	59471000	USD
CY2015Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	51752000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales RealEstateInventoryCapitalizedInterestCostsCostOfSales	99488000	USD
CY2014Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	44603000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	127041000	USD
CY2014Q3	us-gaap	Revenue Other Financial Services RevenueOtherFinancialServices	247000	USD
	us-gaap	Revenue Other Financial Services RevenueOtherFinancialServices	1147000	USD
CY2015Q3	us-gaap	Revenue Other Financial Services RevenueOtherFinancialServices	0	USD
	us-gaap	Revenue Other Financial Services RevenueOtherFinancialServices	0	USD
CY2014Q3	us-gaap	Revenues Revenues	589214000	USD
	us-gaap	Revenues Revenues	1604908000	USD
CY2015Q3	us-gaap	Revenues Revenues	843157000	USD
	us-gaap	Revenues Revenues	2046247000	USD
CY2013Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	92214000	USD
CY2014Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	90458000	USD
CY2014Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	88309000	USD
CY2014Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	86574000	USD
CY2015Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	80136000	USD
CY2015Q3	us-gaap	Self Insurance Reserve SelfInsuranceReserve	80601000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72897000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	205715000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	95074000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	244678000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5959000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10444000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9992609	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	130384	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	18400000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11735042	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11552658	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.45
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.47
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	6455000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	0	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.38
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.26
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	18400000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M0D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y5M0D
CY2013Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	48704000	USD
CY2014Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	40937000	USD
CY2014Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	42396000	USD
CY2014Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	45196000	USD
CY2015Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	46472000	USD
CY2015Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	48642000	USD
CY2014Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	10633000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	30795000	USD
CY2015Q3	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	5285000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	19927000	USD
CY2014Q3	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	4546000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	12332000	USD
CY2015Q3	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	6325000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	15209000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	52000	shares
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	436000	USD
CY2015Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	4000000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1595910000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	1640226000	USD
CY2014Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	13684000	USD
CY2015Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	11935000	USD
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	446476000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	446776000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	300000	USD
CY2014Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	73000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	159000	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	63000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	115000	USD
CY2014Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	73000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	159000	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	63000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	115000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	100000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	100000	USD
CY2014Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	825200000	USD
CY2015Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102070000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98614000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101874000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101605000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91793000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88389000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92065000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92005000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies may use either a full retrospective or a modified retrospective approach to adopt ASU 2014-09. In August 2015, the FASB issued Accounting Standards Update No. 2015-14, “Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date,” which delayed the effective date of ASU 2014-09 by one year. ASU 2014-09, as amended, is effective for public companies for annual reporting periods beginning after December 15, 2017, including interim reporting periods within that reporting period. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2015, the FASB issued Accounting Standards Update No. 2015-01, “Income Statement — Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items”</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">(“ASU 2015-01”). ASU 2015-01 eliminates the concept of extraordinary items from GAAP but retains the presentation and disclosure guidance for items that are unusual in nature or occur infrequently and expands the guidance to include items that are both unusual in nature and infrequently occurring. ASU 2015-01 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. A reporting entity may apply ASU 2015-01 prospectively. A reporting entity may also apply ASU 2015-01 retrospectively to all periods presented in the financial statements. We believe the adoption of ASU 2015-01 will not have a material effect on our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2015, the FASB issued Accounting Standards Update No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis”</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">(“ASU 2015-02”). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. ASU 2015-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We believe the adoption of ASU 2015-02 will not have a material effect on our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the FASB issued Accounting Standards Update No. 2015-03, “Interest — Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">(“ASU 2015-03”). ASU 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. For public entities, ASU 2015-03 is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted for financial statements that have not been previously issued. ASU 2015-03 is to be applied on a retrospective basis and represents a change in accounting principle. We believe the adoption of ASU 2015-03 will not have a material effect on our consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2015, the FASB issued Accounting Standards Update No. 2015-15, “Interest — Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements — Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015 EITF Meeting”</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">(“ASU 2015-15”), which clarifies the treatment of debt issuance costs from line-of-credit arrangements after the adoption of ASU 2015-03. In particular, ASU 2015-15 clarifies that the SEC staff would not object to an entity deferring and presenting debt issuance costs related to a line-of-credit arrangement as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of such arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. We believe the adoption of ASU 2015-15 will not have a material effect on our consolidated financial statements.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">Certain amounts in our consolidated financial statements for prior years have been reclassified to conform to the current period presentation.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000795266-15-000056-index-headers.html	Edgar Link	pending
0000795266-15-000056-index.html	Edgar Link	pending
0000795266-15-000056.txt	Edgar Link	pending
0000795266-15-000056-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kbh-08312015x10q.htm	Edgar Link	pending
kbh-08312015xexhibit1059.htm	Edgar Link	pending
kbh-08312015xexhibitx311.htm	Edgar Link	pending
kbh-08312015xexhibitx312.htm	Edgar Link	pending
kbh-08312015xexhibitx321.htm	Edgar Link	pending
kbh-08312015xexhibitx322.htm	Edgar Link	pending
kbh-20150831.xml	Edgar Link	completed
kbh-20150831.xsd	Edgar Link	pending
kbh-20150831_cal.xml	Edgar Link	unprocessable
kbh-20150831_def.xml	Edgar Link	unprocessable
kbh-20150831_lab.xml	Edgar Link	unprocessable
kbh-20150831_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KBH
KB HOME Stock $kbh

2015 Q3 Form 10-Q Financial Statement

#000079526615000056 Filed on October 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBH KB HOME Stock $kbh

2015 Q3 Form 10-Q Financial Statement

#000079526615000056 Filed on October 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBH
KB HOME Stock $kbh